Clinical trial Recruiting at 1 site Interventional Ages 12 to 65

How brain function changes after brain stimulation in depression treated with ECT or MST

Official title: Investigating Functional Changes in the Frontotemporal Cortex of Patients With Major Depressive Disorder Following Electroconvulsive Therapy or Magnetic Seizure Therapy Using Functional Near-infrared Spectroscopy

Run by The Second Hospital of Anhui Medical University · NCT07533773 · Data updated 2026-11-12

This study tests whether electroconvulsive therapy or magnetic seizure therapy, paired with a quick brain scan (fNIRS), can reveal brain function changes in people with major depressive disorder.

Quick facts

Study typeInterventional
Ages12 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorThe Second Hospital of Anhui Medical University
Academic / other
Locations1 site (Hefei, Anhui)
StatusRecruiting
StartedApril 30, 2026
Main results expectedApril 30, 2029
Study endsApril 30, 2029
Registry record updatedJuly 17, 2026
Trial IDNCT07533773 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults diagnosed with a current major depressive episode who are candidates for ECT or MST and can complete fNIRS assessments.

Probably not a fit

Individuals not showing measurable brain changes with fNIRS or who do not respond to ECT/MST may not experience detectable benefits.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study uses resting-state and task-based functional near-infrared spectroscopy to observe brain hemodynamics before and after treatment with electroconvulsive therapy or magnetic seizure therapy in adults with major depressive disorder. It aims to compare how these two neuromodulation approaches affect frontotemporal brain function and related cognitive processes. The study emphasizes the potential of a simple, noninvasive assessment method to complement cognitive testing and understand treatment-related brain changes. Eligible participants have a current depressive episode, adequate education, and consent to participate, with exclusions for certain co-morbid conditions and recent ECT/MST exposure. The study is led by The Second Hospital of Anhui Medical University in Hefei, China.

Why it matters

Potential benefit: Finding brain-function changes linked to ECT or MST could help tailor treatments and monitoring for depression.

How similar studies have gone: Prior research using neuromodulation and neuroimaging has shown brain-function changes, but direct comparisons between ECT and MST with fNIRS are limited and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A depressive episode diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), confirmed by two psychiatrists;
* Meets the treatment criteria for ECT or MST;
* At least 5 years of education, with no significant hearing or visual impairments;
* Voluntary participation in this study, with a signed written informed consent form, and willingness to cooperate with the collection of general demographic information, neuropsychological testing, and fNIRS resting-state and task-based data acquisition.

Exclusion Criteria:

* Co-occurring mental disorders (such as substance use disorders or schizoaffective disorder);
* Severe physical illness;
* History of neurological disorders (such as traumatic brain injury or dementia);
* Low educational attainment;
* Receipt of ECT or MST treatment within the past six months.

Where it's running

  • The Second Affiliated Hospital of Anhui Medical University
    Hefei, Anhui, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.